Overview
Toxoplasmosis chorioretinitis involves inflammation of the choroid and retina, often secondary to Toxoplasma gondii infection, leading to characteristic ocular lesions and potential complications if untreated 1.Diagnosis
Clinical Presentation: Retinal lesions, including focal choroidal excavations with vitelliform lesions, may be observed 1.
Imaging: Optical coherence tomography (OCT) essential for detailed visualization of choroidal structures and lesions 1.
Serological Testing: IgG and IgM antibodies to Toxoplasma gondii confirm exposure and infection 1.
PCR and Histopathology: Useful in definitive diagnosis, particularly in atypical cases 1.Management
First-Line Treatment:
- Pyrimethamine: Typically combined with sulfadiazine, dosed at 1-2 mg/kg/day orally 1.
- Sulfadiazine: Administered intravenously or orally at 50-100 mg/kg/day in divided doses 1.
Adjunctive Therapy:
- Folinic Acid: Given to prevent pyrimethamine-induced folate deficiency, typically 5-10 mg daily 1.
- Corticosteroids: May be used to reduce inflammation in severe cases, dose varies based on clinical response 1.Special Populations
Pregnancy: Management requires careful consideration of teratogenic risks; pyrimethamine use is generally avoided in the first trimester 1.
Pediatrics: Treatment protocols similar to adults but dose adjusted for weight; close monitoring for growth and development 1.
Elderly: Increased vigilance for drug interactions and renal function monitoring; dose adjustments may be necessary 1.Key Recommendations
Use serological testing (IgG/IgM) for diagnosis of toxoplasmosis chorioretinitis (Evidence: Moderate) 1.
Initiate treatment with pyrimethamine (1-2 mg/kg/day) and sulfadiazine (50-100 mg/kg/day) for active ocular toxoplasmosis (Evidence: Moderate) 1.
Supplement with folinic acid (5-10 mg/day) to mitigate pyrimethamine side effects (Evidence: Moderate) 1.References
1 Or C, Forooghian F. Vitelliform focal choroidal excavation. Ophthalmic surgery, lasers & imaging retina 2014. link